NCT00780052
- Conditions
- Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
- Locations
-
- University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States
Clinical trial condition
Hematologic Neoplasms
Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.
1,027 public trials
268 recruiting studies
Hematologic Neoplasms trial results
Completed
Early Antibiotic Discontinuation in FUO
NCT02906254
- Conditions
- Agranulocytosis, Cytopenia, Febrile Neutropenia, +9 more
- Locations
-
- CHRU de Brest Brest, France
NCT00800839
- Conditions
- Graft vs Host Disease, Hematologic Diseases, Hematologic Neoplasms, +12 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT01527838
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Chronic Disease, +26 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program Boston, Massachusetts, United States
- Ohio State Univeristy Comprehensive Cancer Center Columbus, Ohio, United States
NCT02880709
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancy, +3 more
- Locations
-
- Hematological clinic Copenhagen, Denmark
NCT01416025
- Conditions
- Bacterial Infections and Mycoses, Fungal Infection, Hematologic Diseases, +6 more
- Locations
-
- Johns Hopkins Baltimore, Maryland, United States
NCT00642031
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +24 more
- Locations
-
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- UT MD Anderson Cancer Center Houston, Texas, United States
Completed
Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN)
NCT02859623
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Hematologic Diseases, Hematologic Neoplasms, +11 more
- Locations
-
Not specified
NCT00133367
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Graft vs Host Disease, +27 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Completed
Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies
NCT01871675
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
- Locations
-
- The Colorado Blood Cancer Institute Denver, Colorado, United States
- Florida Cancer Specialists Sarasota, Florida, United States
- Oklahoma University Oklahoma City, Oklahoma, United States
- Tennessee Oncology, PLLC Nashville, Tennessee, United States